Cargando…
Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma: A retrospective, propensity score-matched study
BACKGROUND: The benefit of neoadjuvant chemotherapy for patients with signet-ring cell carcinoma of the stomach is controversial. AIM: To evaluate the perioperative and long-term outcomes of neoadjuvant chemotherapy for locally advanced gastric signet-ring cell carcinoma. METHODS: This retrospective...
Autores principales: | Li, Yang, Ma, Fu-Hai, Xue, Li-Yan, Tian, Yan-Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052534/ https://www.ncbi.nlm.nih.gov/pubmed/32148379 http://dx.doi.org/10.3748/wjg.v26.i8.818 |
Ejemplares similares
-
Laparoscopic vs open total gastrectomy for advanced gastric cancer following neoadjuvant therapy: A propensity score matching analysis
por: Hu, Hai-Tao, et al.
Publicado: (2022) -
Prognostic significance of preoperative lymphocyte to monocyte ratio in patients with signet ring gastric cancer
por: Liu, He-Li, et al.
Publicado: (2023) -
Protective effects of female reproductive factors on gastric signet-ring cell carcinoma
por: Li, Yang, et al.
Publicado: (2022) -
Clinicopathological characteristics and prognosis of gastric signet ring cell carcinoma
por: Tian, Hua-Kai, et al.
Publicado: (2022) -
Postoperative morbidity and mortality after neoadjuvant chemotherapy versus upfront surgery for locally advanced gastric cancer: a propensity score matching analysis
por: Wu, Liucheng, et al.
Publicado: (2019)